非西班牙裔黑人非酒精性脂肪性肝病患者晚期纤维化、肝硬化和肝脏相关事件发生率较低,即使控制临床危险因素和PNPLA3基因型后亦然
该研究比较了109例非西班牙裔黑人和1910例非西班牙裔白人活检证实的非酒精性脂肪性肝病患者的组织学和结局。但合并晚期纤维化的非西班牙裔黑人患者NAS和小叶炎症分级更高。
要点
- 两组NAS(4.4 vs 4.3,P=0.87)和明确代谢功能障碍相关脂肪性肝炎比例(59% vs 58%,P=1.0)相似。
- 合并晚期纤维化的非西班牙裔黑人患者NAS(5.6 vs 4.9,P=0.01)和小叶炎症分级(2.2 vs 1.7,P<0.002)显著更高。
核心结论
- 控制临床危险因素和PNPLA3基因型后,非西班牙裔黑人非酒精性脂肪性肝病患者晚期纤维化风险显著更低。
- 尽管晚期纤维化风险较低,但合并晚期纤维化的非西班牙裔黑人患者NAS和小叶炎症更高,提示坏死性炎症与纤维化关系存在差异。
研究设计与样本
- 比较109例非西班牙裔黑人和1910例非西班牙裔白人活检证实的非酒精性脂肪性肝病成人患者,数据来自非酒精性脂肪性肝炎临床研究网络观察性研究。
- 通过多变量逻辑回归评估自我报告的非西班牙裔黑人种族/民族与晚期纤维化的关系,控制临床协变量和PNPLA3基因型。
主要发现
- 非西班牙裔黑人和非西班牙裔白人非酒精性脂肪性肝病患者的NAS相似(4.4 vs 4.3,P=0.87),明确代谢功能障碍相关脂肪性肝炎比例相似(59% vs 58%,P=1.0)。
- 非西班牙裔黑人晚期纤维化发生率显著低于非西班牙裔白人(22% vs 34%,P=0.01),肝硬化发生率亦显著更低(4.6% vs 12.1%,P=0.010)。
- 在24例非西班牙裔黑人和655例非西班牙裔白人合并晚期纤维化的比较中,非西班牙裔黑人NAS(5.6 vs 4.9,P=0.01)和小叶炎症分级(2.2 vs 1.7,P<0.002)显著更高。
- 随访期间1例非西班牙裔黑人和23例非西班牙裔白人死亡(每100人年随访0.30 vs 0.28);非西班牙裔白人发生7例肝脏相关死亡,非西班牙裔黑人0例。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) is less frequent in non-Hispanic persons (NHB), but there are knowledge gaps in our understanding of disease severity and outcomes of NAFLD in NHB. We compared liver histology and clinical outcomes of NAFLD in non-Hispanic Black persons (NHB) and non-Hispanic White persons (NHW). METHODS: We compared liver histology and outcomes of 109 NHB and 1,910 NHW adults with biopsy-proven NAFLD participating in the Nonalcoholic Steatohepatitis Clinical Research Network observational studies. The relationship between self-reported NHB race/ethnicity and advanced fibrosis was assessed through multivariable logistic regression after controlling for clinical covariates and PNPLA3 genotype. RESULTS: NHB and NHW with NAFLD had similar NAFLD activity scores (NAS, 4.4 vs 4.3, P = 0.87) and proportions with definite metabolic dysfunction-associated steatohepatitis (59% vs 58%, P = 1.0), but NHB had significantly lower rates of advanced fibrosis (22% vs 34%, P = 0.01) or cirrhosis (4.6% vs 12.1%, P = 0.010). Compared with NHW, NHB had significantly lower frequency of advanced fibrosis (Odds Ratio: 0.48, 95% Confidence Interval: 27-0.86, P = 0.01). In a comparison between 24 NHB and 655 NHW with advanced fibrosis, the NAS (5.6 vs 4.9, P = 0.01) and lobular inflammation grade (2.2 vs 1.7, P < 0.002) were significantly higher among NHB with advanced fibrosis. One NHB and 23 NHW died during follow-up (0.30 vs 0.28 per 100 person-year follow-up). Seven and zero liver-related deaths occurred in NHW and NHB with NAFLD, respectively. DISCUSSION: The risk of advanced fibrosis in NHB with NAFLD is significantly lower, after controlling for clinical risk factors and PNPLA3 genotype. Although their risk of advanced fibrosis was low, NHB with NAFLD and advanced fibrosis had higher NAS and lobular inflammation, indicating a difference in their relationship between necroinflammation and fibrosis.
引用
- Samala N, Xin Y, Wilson LA, et al. Non-Hispanic Black Persons With Nonalcoholic Fatty Liver Disease Have Lower Rates of Advanced Fibrosis, Cirrhosis, and Liver-Related Events Even After Controlling for Clinical Risk Factors and PNPLA3 Genotype. Am J Gastroenterol. 2024. PMID: 38483303. doi:10.14309/ajg.0000000000002756
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。